Nephros, Inc.
corporate_fare Company Profile
Nephros, Inc. (NASDAQ:NEPH) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 11 items for NEPH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 11 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for NEPH spans 8-K, 10-Q, 10-K.
Recent high-impact activity:
- Q3 Revenue Climbs 18% to $5.6M as Nephros Stays Profitable
- Nephros Q3 2026: Revenue Up 18% to $5.6M, Net Income $0.5M
- Nephros Q3 10-Q: Profit Holds, But Material Weakness Keeps Controls 'Not Effective'
- Nephros Q2 Revenue Surges 36% to $6M, Net Income Hits $1.2M, but Material Weakness Lingers
- Nephros Q2 Revenue Surges 36%, Beats Estimates by 20%
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 11,913 shares in NEPH as of the October 30, 2026 settlement, a 22.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 19, 2026, 60.7% of NEPH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.